Literature DB >> 33086021

Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus1.

Tasnim H Beacon1, Geneviève P Delcuve1, James R Davie2.   

Abstract

The angiotensin-converting enzyme 2 (ACE2) is the receptor for the three coronaviruses HCoV-NL63, SARS-CoV, and SARS-CoV-2. ACE2 is involved in the regulation of the renin-angiotensin system and blood pressure. ACE2 is also involved in the regulation of several signaling pathways, including integrin signaling. ACE2 expression is regulated transcriptionally and post-transcriptionally. The expression of the gene is regulated by two promoters, with usage varying among tissues. ACE2 expression is greatest in the small intestine, kidney, and heart and detectable in a variety of tissues and cell types. Herein we review the chemical and mechanical signal transduction pathways regulating the expression of the ACE2 gene and the epigenetic/chromatin features of the expressed gene.

Entities:  

Keywords:  SARS-CoV-2; angiotensin-converting enzyme 2 (ACE2); enzyme de conversion de l’angiotensine 2 (ACE2); epigenetic; genome organization; histone and DNA modifications; modifications de l’ADN et des histones; organisation du génome; épigénétique

Year:  2020        PMID: 33086021     DOI: 10.1139/gen-2020-0124

Source DB:  PubMed          Journal:  Genome        ISSN: 0831-2796            Impact factor:   2.166


  8 in total

1.  Exercise-induced myokines downregulates the ACE2 level in bronchial epithelial cells: Implications for SARS-CoV-2 prevention.

Authors:  Vaishali Bhardwaj; Mart Dela Cruz; Deepika Subramanyam; Rohit Kumar; Sandeep Markan; Beth Parker; Hemant K Roy
Journal:  PLoS One       Date:  2022-07-20       Impact factor: 3.752

2.  Age and sex effects on DNA methylation sites linked to genes implicated in severe COVID-19 and SARS-CoV-2 host cell entry.

Authors:  Jon Bohlin; Christian M Page; Yunsung Lee; John H-O Pettersson; Astanand Jugessur; Per Magnus; Siri E Håberg
Journal:  PLoS One       Date:  2022-06-09       Impact factor: 3.752

Review 3.  Epigenetics at the Intersection of COVID-19 Risk and Environmental Chemical Exposures.

Authors:  Catherine M Bulka; Adam E Enggasser; Rebecca C Fry
Journal:  Curr Environ Health Rep       Date:  2022-06-01

Review 4.  Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation.

Authors:  Anthony J Turner; Natalia N Nalivaeva
Journal:  Peptides       Date:  2022-02-10       Impact factor: 3.750

5.  Identification of cell type specific ACE2 modifiers by CRISPR screening.

Authors:  Emily J Sherman; Carmen Mirabelli; Vi T Tang; Taslima G Khan; Kyle Leix; Andrew A Kennedy; Sarah E Graham; Cristen J Willer; Andrew W Tai; Jonathan Z Sexton; Christiane E Wobus; Brian T Emmer
Journal:  PLoS Pathog       Date:  2022-03-01       Impact factor: 6.823

6.  Expression analysis of miRNA hsa-let7b-5p in naso-oropharyngeal swabs of COVID-19 patients supports its role in regulating ACE2 and DPP4 receptors.

Authors:  Andrea Latini; Chiara Vancheri; Francesca Amati; Elena Morini; Sandro Grelli; Matteucci Claudia; Petrone Vita; Vito Luigi Colona; Michela Murdocca; Massimo Andreoni; Vincenzo Malagnino; Massimiliano Raponi; Dario Cocciadiferro; Antonio Novelli; Paola Borgiani; Giuseppe Novelli
Journal:  J Cell Mol Med       Date:  2022-09-08       Impact factor: 5.295

Review 7.  Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19.

Authors:  Jesús Zepeda-Cervantes; Daniel Martínez-Flores; Josué Orlando Ramírez-Jarquín; Ángeles C Tecalco-Cruz; Noé Santiago Alavez-Pérez; Luis Vaca; Rosa Elena Sarmiento-Silva
Journal:  Viruses       Date:  2022-01-06       Impact factor: 5.048

Review 8.  The dynamic broad epigenetic (H3K4me3, H3K27ac) domain as a mark of essential genes.

Authors:  Tasnim H Beacon; Geneviève P Delcuve; Camila López; Gino Nardocci; Igor Kovalchuk; Andre J van Wijnen; James R Davie
Journal:  Clin Epigenetics       Date:  2021-07-08       Impact factor: 6.551

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.